Home Stocks Marksans Pharma Ltd

Marksans Pharma Ltd

The live share price of Marksans Pharma Ltd (MARKSANS) as on 07 May 9:31am is ₹158.35 from NSE/BSE.

MARKSANS NSE

₹158.35 ▼-3.45% (-5.65)

As on May 07, 2024 03:01 PM IST

How do you feel today about Marksans Pharma Ltd?

Bearish or

Bullish

Bearish or

Bullish

Key Metrics

PE Ratio

23.93

PB Ratio

4.3

Dividend Yield

0.3%

Sector PB

5.98

Sector PE

52.8

Sector Div Yld

0.57%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Smallcap, ₹7,595 Cr

Marksans Pharma Limited is a pharmaceutical company, which is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations.

The following charts display the financial performance of the Marksans Pharma Ltd (MARKSANS) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Marksans Pharma Ltd (MARKSANS), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Smallcap, ₹7,595 Cr

Financials

Income Statement

(INR)		Y/Y Change
Revenue	1,911 Cr	+24.71%
Operating Expense	176 Cr	+77.94%
Net Income	266 Cr	+44.3%
Net Profit Margin	13.93%	+15.7%
Earning Per Share	6	+37.07%
EBITDA	398 Cr	+32.55%

Balance sheet

(INR)		Y/Y Change
Cash & short-term Inv	715 Cr	+104.6%
Total Assets	2,190 Cr	+33.87%
Total Liabilities	425 Cr	+2.91%
Total Equity	1,765 Cr	+44.33%
Shares Outstanding	45.32 Cr	+10.72%
Price to Book	1.81	+3.31%
Return on Assets	13.92%	+7.99%
Return on Capital	19.65 Cr	-6.12%

Cash Flows

(INR)		Y/Y Change
Net Income	266 Cr	+44.3%
Cash from Operations	237 Cr	+139.18%
Cash from Investing	-259 Cr	+521.76%
Cash from Financing	197 Cr	+148.81%
Net Change in Cash	176 Cr	+28.41%
Free Cash Flow	183 Cr	+247.21%

Shareholding Pattern

Total Promoter Holding

43.85%

Unpledged

Foreign Institutions

15.57%

Foreign Institutions

Retail & Others

35.4%

Retail & Others

Other Parties

Other Domestic Institutions

0.95%

Insurance Firms

Others

Mutual Funds

4.23%

Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

40.92

1Y Return

▲58.98%

CIPLA

Cipla Ltd

PE Ratio

30.92

1Y Return

▲52.51%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

20.03

1Y Return

▲28.25%

ZYDUSLIFE

Zydus Lifesciences Ltd

PE Ratio

33.43

1Y Return

▲94.28%

Latest News

Marksans Pharma’s Goa Facility Receives Form 483 With Five Observations From U.S. FDA

3 weeks ago on Bloomberg Quint

Change since news ▼-INF%

Marksans Pharma’s Goa facility receives Form 483 with five observations from U.S. FDA after routine cGMP inspection.

USFDA issues Form 483 with five inspectional observations to Marksans Pharma’s Goa unit

3 weeks ago on Moneycontrol

Change since news ▼-INF%

The US Food and Drug Administration (USFDA) had conducted a routine current Good Manufacturing Practices (cGMP) inspection at the manufacturing facility from April 9-17, 2024, the company said in a regulatory filing.

FAQs on Marksans Pharma Ltd

How to buy Marksans Pharma Ltd stocks?

You can easily buy the stocks/shares of Marksans Pharma Ltd (MARKSANS) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Marksans Pharma Ltd?

The stock price of Marksans Pharma Ltd as on 07 May 2024 is ₹158.35

What is the 52-week High and Low of Marksans Pharma Ltd?

The 52-week high and low of Marksans Pharma Ltd (MARKSANS) is ₹185.5 and ₹70.55.

What is the PE and PB ratio of Marksans Pharma Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Marksans Pharma Ltd are 23.93 and 4.3 respectively.

What are the peers or stocks similar to Marksans Pharma Ltd?

The peers or stocks similar to Marksans Pharma Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Zydus Lifesciences Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Marksans Pharma Ltd belong to?

Marksans Pharma Ltd (MARKSANS) belongs to the Pharmaceuticals sector.

What is the Market Cap of Marksans Pharma Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Marksans Pharma Ltd (MARKSANS) is ₹7,595 Cr as of 07 May 2024

Can't decide whether or not to buy Marksans Pharma Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.

Dislaimer: This platform is intended for informational purposes only and is not intended to provide investment advice. The stock prices displayed are delayed and may not reflect the most current market conditions. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. You can also consider consulting a financial advisor before making any investment decisions. Smallcase Technologies Private Limited shall not be responsible for any losses that may occur as a result of using this platform.